共 90 条
[1]
Kearon C(2016)Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report Chest 149 315-352
[2]
Akl EA(2016)Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH J Thromb Haemost 14 1480-1483
[3]
Ornelas J(2019)Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis BMJ 366 l4363-3073
[4]
Kearon C(2014)2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism Eur Heart J 35 3033-900
[5]
Ageno W(2003)Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis Ann Intern Med 139 893-1434
[6]
Cannegieter SC(2003)Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism N Engl J Med 348 1425-694
[7]
Khan F(2015)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement Syst Rev 4 1-1594
[8]
Rahman A(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 b2535-432
[9]
Carrier M(2005)Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 692-793
[10]
Konstantinides SV(2018)Venous thromboembolism: advances in diagnosis and treatment JAMA 320 1583-460